Intralymphatic immunotherapy in pollen allergic young adults with rhinoconjunctivitis and mild asthma: a randomized trial.
Four intralymphatic allergen injections for treatment of pollen allergy reduce medication use, improve symptoms and have immune modulating effects in adolescents and young adults with rhinoconjunctivitis and mild asthma due to birch or grass pollen.